Advertisement
Research Article

MicroRNA Expression Analysis: Clinical Advantage of Propranolol Reveals Key MicroRNAs in Myocardial Infarction

  • Wenliang Zhu,

    Affiliation: Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

    X
  • Lei Yang,

    Affiliation: The First Affiliated Hospital of Harbin Medical University, Harbin, China

    X
  • Hongli Shan,

    Affiliation: Department of Pharmacology, Harbin Medical University, Harbin, China

    X
  • Yong Zhang,

    Affiliation: Department of Pharmacology, Harbin Medical University, Harbin, China

    X
  • Rui Zhou,

    Affiliation: Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

    X
  • Zhe Su,

    Affiliation: Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

    X
  • Zhimin Du mail

    dzm1956@126.com

    Affiliation: Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

    X
  • Published: February 28, 2011
  • DOI: 10.1371/journal.pone.0014736

About the Authors

Wenliang Zhu, Rui Zhou, Zhe Su, Zhimin Du
Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
Lei Yang
The First Affiliated Hospital of Harbin Medical University, Harbin, China
Hongli Shan, Yong Zhang
Department of Pharmacology, Harbin Medical University, Harbin, China

Corresponding Author

Email: dzm1956@126.com

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: WZ LY HS ZD. Performed the experiments: WZ LY HS YZ. Analyzed the data: WZ LY HS RZ ZS. Contributed reagents/materials/analysis tools: WZ HS. Wrote the paper: WZ ZD.